COVID-19 Tied to Progression of Chronic Liver Disease
TUESDAY, June 21, 2022 -- About one in five patients with chronic liver disease (CLD) develop progressive cholestasis after severe COVID-19, according to a study published online May 21 in Hepatology.
Lukas Hartl, M.D., from University of Vienna,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cholestasis | COVID-19 | Liver | Liver Disease | Pharmaceuticals | Study | Urology & Nephrology